Who is sponsoring NCT06022614?

NCT06022614 is sponsored by Abanoub Habib.

What drugs are being tested in NCT06022614?

Interventions in NCT06022614: Use Bupivacaine 0.25% Injectable Solution, Bupivacaine 0.25% Injectable Solution plus Dexmedetomidine.

What condition does NCT06022614 study?

NCT06022614 studies Erector Spinae Plane Block.

Is NCT06022614 still recruiting?

NCT06022614 is currently completed. Last updated 2 October 2024.

Last reviewed 2024-10-02 · How we verify

NCT06022614

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Adding Dexmedetomidine As Adjuvant to Bupivacaine in US Guided ESPB for Post MRM Pain Management

Completed NA Last updated 2 October 2024

What this trial tests

NA trial testing Use Bupivacaine 0.25% Injectable Solution in Erector Spinae Plane Block in 60 participants. Completed in 1 July 2024.

Timeline

15 August 2023

Primary endpoint
1 June 2024

1 July 2024

Quick facts

Lead sponsor	Abanoub Habib
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	60
Start date	15 August 2023
Primary completion	1 June 2024
Estimated completion	1 July 2024
Sites	1 location across Egypt

Drugs / interventions tested

Use Bupivacaine 0.25% Injectable Solution — full drug profile →
Bupivacaine 0.25% Injectable Solution plus Dexmedetomidine — full drug profile →

Conditions studied

Erector Spinae Plane Block — all drugs for Erector Spinae Plane Block →

Sponsor

Abanoub Habib — full company profile →

Who can join

Adults 30 to 65, female only, with Erector Spinae Plane Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to assess the effect of adding dexmedetomidine to bupivacaine in US guided erector spinae plane block in modified radical mastectomy surgeries , Using visual analogue score and post-operative narcotics consumption. Peripheral nerve blocks are effective adjuvant options for pain management in breast surgeries. The use of Erector spinae plane block (ESPB) has been proven to be very effective in controlling pain and minimizing narcotic consumption after modified radical mastectomy surgeries. Many adjuvants to local anaesthetics were used to improve the duration and intensity of the peripheral nerve block.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of adding dexmedetomidine as an adjuvant to bupivacaine in ultrasound-guided erector spinae plane block for postoperative pain management following modified radical mastectomy: a randomized controlled trial.
Feltaoos AM, Abdelhamed HS, Kamal KY, Elagamy AE, et al · · 2026 · PMID 41781939 · DOI 10.1186/s12893-026-03557-0

Verify or expand the search:

Other recruiting trials for Erector Spinae Plane Block

Currently open trials in the same condition.

NCT07509957 — Effect of Preoperative Erector Spinae Plane Block on Recovery Quality, Time to Return to Daily Activities, and Postopera · NA · recruiting
NCT07367568 — Costotransverse Foramen Block With Erector Spinae Plane Block in Modified Radical Mastectomy · NA · recruiting
NCT07272577 — Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Laparoscopic Abdominal Surgeries · NA · recruiting
NCT07251400 — Analgesic Efficacy of Erector Spinae and Rectus Sheath Block in Patients Undergoing Laparoscopic Inguinal Hernia Repair · NA · active not recruiting
NCT07201285 — Edge of Laminar Block Versus Erector Spinae Plane Block for Postoperative Analgesia in Video-Assisted Thoracoscopic Surg · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06022614 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Abanoub Habib
Last refreshed: 2 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06022614.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing